Mer­ck, Evax­ion ex­pand col­lab­o­ra­tion with in­fec­tious dis­ease vac­cine pact

Mer­ck has inked an op­tion and li­cense agree­ment with Evax­ion Biotech for two of its AI-de­signed vac­cine can­di­dates, bol­ster­ing an ex­ist­ing re­la­tion­ship be­tween the drug­mak­ers …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER